---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-164186"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2026-04-20T23:59:59+00:00"
generated_at: "2026-05-15T05:25:56.492147+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nektar reports estimated cash and investments of $741.7M as of April 1, 2026

## Summary
- Cash and marketable securities estimated at $741.7 million as of April 1, 2026.
- Announcement is a preliminary estimate, not a comprehensive financial statement.
- Amount based solely on information available as of April 20, 2026 filing date.
- No other financial results or guidance provided in the release.

## SEC filing metadata
- accession: 0001193125-26-164186
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2026-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000119312526164186/0001193125-26-164186-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000119312526164186/d136533d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-164186
- JSON: https://secwatch.observer/filing/0001193125-26-164186.json
- Plain text: https://secwatch.observer/filing/0001193125-26-164186.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.